BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy

The trial will compare the current standard of pain care monitoring to Baeta's device which facilitates accurate data collection

Online PR News – 18-May-2011 – – Fort Lee, NJ, May 17, 2011 -- BAETA Corp. (OTCBB:BAEA.ob - News) announced today that the NYU School of Medicine will conduct a clinical trial to measure the efficacy of the Company's "MyHealthTrends for Pain" handheld device during intra-operative, pre- and post-surgical periods. This trial will compare the current standard of pain care monitoring to Baeta's device which facilitates accurate data collection.

Michael Haile, MD, director of Clinical Research at NYU School of Medicine will oversee the initiative as the Principal Investigator.  "We are interested in the practical application of a portable, handheld device for patients to quantify pain and the ability to translate this information into enhanced treatment regimens and outcomes relative to the current standard of pain care monitoring," said Dr. Haile.

The protocol has been reviewed and approved by NYU School of Medicine's Institutional Review Board (IRB).

"We look forward to the opportunity to determine if the standard of pain care monitoring can be advanced using this technology," said Dr. Alexander Gak, Chairman of Baeta Corp. "With limited tools to quantify pain, this is an important initiative for any individual suffering from acute or chronic pain," said Gak.

Upon conclusion of the clinical trial Baeta intends to apply for a CPT reimbursement code. "This is an important step for Baeta Corp's commercialization of its advanced patient care products," stated Len Pushkantser, CEO of Baeta Corp. Physicians, hospitals, and other health care providers use CPT codes to report medical services to private and public health insurance systems for purposes of reimbursement.

About Baeta Corp.
Baeta Corp. (OTC.BB:BAEA.ob - News) is a technology-enabled health improvement company whose objective is to empower patients to elevate their role in the prevention, diagnosis, treatment, and recovery from illnesses. Baeta Corp. develops innovative, technology-driven healthcare information solutions enabling patients to easily capture health-related data. Please visit Baeta Corp. at for more information about our products.

Not a Broker/Dealer or Financial Advisor

Baeta Corp. is not a Registered Broker/Dealer or a Financial Advisor, nor does it hold itself out to be a Registered Broker/Dealer or Financial Advisor. All material presented in this press release, on the Company's website or other media is not to be regarded as investment advice and is only for informative purposes. Readers should verify all claims and conduct their own due diligence before investing in Baeta Corp. Investing in small-cap, micro cap and penny stock securities is speculative and carries a high degree of risk.

No Offer of Securities

None of the information featured in this press release constitutes an offer or solicitation to purchase or to sell any securities of Baeta Corp.


Information presented in this press release contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements." Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects," "foresee," "expects," "will," "anticipates," "estimates," "believes," "understands," or that by statements indicating certain actions "may," "could," or "might" occur. Understand there is no guarantee past performance will be indicative of future results.

None of the information contained son the Baeta Corp. website is incorporated by reference herein.
Suzanne Holbrook

For additional information, please contact: Baeta Corp., Mr. Leonid Pushkantser, Chief Executive Officer, 1 Bridge, Plaza Suite 275, Fort Lee, NJ 07024, (201) 471-0988, Extension 106,,

Contact :
Mr. Leonid Pushkantser
Chief Executive Officer
Baeta Corp.
1 Bridge Plaza Suite 275
Fort Lee, NJ 07024

Contact Information
Mr. Leonid Pushkantser
Baeta Corp.